Suivre
Xavier Barbeau
Xavier Barbeau
NuChem Sciences
Adresse e-mail validée de nuchemsciences.com
Titre
Citée par
Citée par
Année
Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method
JP Iyombe-Engembe, DL Ouellet, X Barbeau, J Rousseau, ...
Molecular Therapy-Nucleic Acids 5, 2016
962016
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia
S Krishnamurthy, C Wohlford-Lenane, S Kandimalla, G Sartre, ...
Nature communications 10 (1), 4906, 2019
942019
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
T Del’Guidice, JP Lepetit-Stoffaes, LJ Bordeleau, J Roberge, V Théberge, ...
PloS one 13 (4), e0195558, 2018
812018
CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo
BL Duchêne, K Cherif, JP Iyombe-Engembe, A Guyon, J Rousseau, ...
Molecular Therapy 26 (11), 2604-2616, 2018
732018
Stereocontrolled approach to bromofluoroalkenes and their use for the synthesis of tri-and tetrasubstituted fluoroalkenes
G Landelle, PA Champagne, X Barbeau, JF Paquin
Organic Letters 11 (3), 681-684, 2009
652009
Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
R Maltais, D Ayan, A Trottier, X Barbeau, P Lagüe, JE Bouchard, ...
Journal of medicinal chemistry 57 (1), 204-222, 2014
432014
Quinazoline‐4‐piperidine sulfamides are specific inhibitors of human NPP 1 and prevent pathological mineralization of valve interstitial cells
EE Shayhidin, E Forcellini, MC Boulanger, A Mahmut, S Dautrey, ...
British journal of pharmacology 172 (16), 4189-4199, 2015
392015
Viral polymerase inhibitors
T Stammers, X Barbeau, P Beaulieu, M Bertrand-laperle, C Brochu, ...
US Patent App. 12/883,677, 2011
342011
Antibiotic resistance due to an unusual ColE1-type replicon plasmid in Aeromonas salmonicida
AT Vincent, JG Emond-Rheault, X Barbeau, SA Attéré, M Frenette, ...
Microbiology 162 (6), 942-953, 2016
332016
Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties
C Ouellet, R Maltais, É Ouellet, X Barbeau, P Lagüe, D Poirier
European Journal of Medicinal Chemistry 119, 169-182, 2016
302016
Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1
E Forcellini, S Boutin, CA Lefebvre, EE Shayhidin, MC Boulanger, ...
European Journal of Medicinal Chemistry 147, 130-149, 2018
242018
Interfacial supramolecular biomimetic epoxidation catalysed by cyclic dipeptides
C Berube, X Barbeau, S Cardinal, PL Boudreault, C Bouchard, N Delcey, ...
Supramolecular Chemistry 29 (5), 330-349, 2017
242017
Revisiting the Juliá–Colonna enantioselective epoxidation: supramolecular catalysis in water
C Bérubé, X Barbeau, P Lagüe, N Voyer
Chemical communications 53 (37), 5099-5102, 2017
212017
Extended linkers improve the detection of protein-protein interactions (PPIs) by dihydrofolate reductase protein-fragment complementation assay (DHFR PCA) in living cells
AÈ Chrétien, I Gagnon-Arsenault, AK Dubé, X Barbeau, PC Després, ...
Molecular & Cellular Proteomics 17 (2), 373-383, 2018
192018
Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activity
R Maltais, A Trottier, X Barbeau, P Laguee, M Perreault, JF Theriault, ...
The journal of steroid biochemistry and molecular biology 161, 24-35, 2016
192016
Identification of fused 16β, 17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors
R Maltais, A Trottier, A Delhomme, X Barbeau, P Lagüe, D Poirier
European Journal of Medicinal Chemistry 93, 470-480, 2015
182015
Insight into the mode of action and selectivity of PBRM, a covalent steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type 1
A Trottier, R Maltais, D Ayan, X Barbeau, J Roy, M Perreault, R Poulin, ...
Biochemical pharmacology 144, 149-161, 2017
172017
Aeromonas salmonicida Ati2 is an effector protein of the type three secretion system
S Dallaire-Dufresne, X Barbeau, D Sarty, KH Tanaka, AM Denoncourt, ...
Microbiology 159 (Pt_9), 1937-1945, 2013
172013
Novel chiral N, N′-dimethyl-1, 4-piperazines with metal binding abilities
C Bérubé, S Cardinal, PL Boudreault, X Barbeau, N Delcey, M Giguère, ...
Tetrahedron 71 (42), 8077-8084, 2015
152015
Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ
C Carpentier, X Barbeau, J Azelmat, K Vaillancourt, D Grenier, P Lagüe, ...
Bioorganic & Medicinal Chemistry 26 (22), 5845-5851, 2018
142018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20